Quantitative Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-37,419
| Closed | -$6.32M | – | 445 |
|
|
2026
Q1 | $6.32M | Buy |
+37,419
| New | +$6.4M | 0.66% | 40 |
|
|
2025
Q4 | – | Sell |
-4,362
| Closed | -$629K | – | 464 |
|
|
2025
Q3 | $629K | Buy |
4,362
+2,734
| +168% | +$373K | 0.09% | 202 |
|
|
2025
Q2 | $205K | Buy |
+1,628
| New | +$200K | 0.03% | 285 |
|
|
2024
Q3 | – | Sell |
-18,071
| Closed | -$2.48M | – | 375 |
|
|
2024
Q2 | $2.48M | Buy |
+18,071
| New | +$2.41M | 0.27% | 78 |
|
|
2022
Q4 | – | Sell |
-25,485
| Closed | -$2.98M | – | 267 |
|
|
2022
Q3 | $2.98M | Sell |
25,485
-60,962
| -71% | -$7.57M | 0.49% | 42 |
|
|
2022
Q2 | $10.2M | Buy |
+86,447
| New | +$10.3M | 1.55% | 11 |
|
|
2021
Q2 | – | Sell |
-71,758
| Closed | -$10.8M | – | 486 |
|
|
2021
Q1 | $10.8M | Buy |
71,758
+36,890
| +106% | +$5.86M | 0.91% | 24 |
|
|
2020
Q4 | $5.28M | Buy |
+34,868
| New | +$4.98M | 0.43% | 47 |
|
|
2018
Q4 | – | Sell |
-7,500
| Closed | -$914K | – | 694 |
|
|
2018
Q3 | $914K | Sell |
7,500
-72,700
| -91% | -$8.56M | 0.03% | 320 |
|
|
2018
Q2 | $8.81M | Buy |
+80,200
| New | +$8.58M | 0.18% | 117 |
|
|
2017
Q4 | – | Sell |
-357,300
| Closed | -$39.7M | – | 811 |
|
|
2017
Q3 | $39.7M | Sell |
357,300
-644,100
| -64% | -$68.8M | 0.45% | 42 |
|
|
2017
Q2 | $104M | Buy |
+1,001,400
| New | +$98.6M | 1.56% | 7 |
|
|
2016
Q4 | – | Sell |
-35,100
| Closed | -$3.39M | – | 857 |
|
|
2016
Q3 | $3.39M | Buy |
+35,100
| New | +$3.34M | 0.11% | 220 |
|
|
2016
Q2 | – | Sell |
-91,800
| Closed | -$7.98M | – | 833 |
|
|
2016
Q1 | $7.98M | Buy |
91,800
+57,600
| +168% | +$5.15M | 0.39% | 53 |
|
|
2015
Q4 | $3.86M | Sell |
34,200
-350,700
| -91% | -$38.1M | 0.23% | 113 |
|
|
2015
Q3 | $38.9M | Buy |
+384,900
| New | +$46.2M | 2.93% | 1 |
|
|
2015
Q1 | – | Sell |
-28,200
| Closed | -$2.85M | – | 676 |
|
|
2014
Q4 | $2.85M | Buy |
+28,200
| New | +$2.74M | 0.44% | 48 |
|
|
2014
Q2 | – | Sell |
-656,400
| Closed | -$51.7M | – | 549 |
|
|
2014
Q1 | $51.7M | Buy |
+656,400
| New | +$54.7M | 2.46% | 7 |
|
|
2013
Q4 | – | Sell |
-17,400
| Closed | -$1.22M | – | 645 |
|
|
2013
Q3 | $1.22M | Sell |
17,400
-26,700
| -61% | -$1.75M | 0.11% | 185 |
|
|
2013
Q2 | $2.56M | Buy |
+44,100
| New | +$2.55M | 0.45% | 39 |
|
Other funds holding IBB
CB
Quantitative Investment Management's IBB Position: Q2 2026 in Review
Quantitative Investment Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 37,419 shares — an estimated $6.32M sold.
Quantitative Investment Management first reported a position in IBB in Q2 2013 and held it in 20 quarters. The position peaked at $104M in Q2 2017. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Quantitative Investment Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
- Quantitative Investment Management sold 37,419 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.32M.
- Quantitative Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 20 quarters.
- Quantitative Investment Management's iShares Biotechnology ETF position peaked at $104M in Q2 2017.
- 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.